Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 1/2000

Ausgabe 1/2000

Inhaltsverzeichnis ( 6 Artikel )

01.03.2000 | ORIGINAL ARTICLE | Ausgabe 1/2000

B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cells

Dorothy K. Sojka, Ross N. La Motte, Margalit B. Mokyr

01.03.2000 | ORIGINAL ARTICLE | Ausgabe 1/2000

Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectins

Shinji Ichii, Yasuyuki Imai, Tatsuro Irimura

01.03.2000 | ORIGINAL ARTICLE | Ausgabe 1/2000

Immune gene therapy of experimental mouse brain tumor with adenovirus-mediated gene transfer of murine interleukin-4

Koichi Yoshikawa, Koji Kajiwara, Makoto Ideguchi, Tetsuya Uchida, Haruhide Ito

01.03.2000 | ORIGINAL ARTICLE | Ausgabe 1/2000

Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy

Nisha Nagarkatti

01.03.2000 | ORIGINAL ARTICLE | Ausgabe 1/2000

Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon γ

Beth A. Pulaski, Virginia K. Clements, Matthew R. Pipeling, Suzanne Ostrand-Rosenberg

01.03.2000 | ORIGINAL ARTICLE | Ausgabe 1/2000

Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer

J. Y. Douillard, J. Bennouna, F. Vavasseur, R. Deporte-Fety, P. Thomare, F. Giacalone, K. Meflah

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise